Form 4 Filing for AMICUS THERAPEUTICS, INC. - Whitman Burke Transaction

On April 27, 2026, Whitman Burke, a director at AMICUS THERAPEUTICS, INC. (FOLD), reported the disposition of 118,598 shares of Common Stock at a price of $14.50 per share. This transaction was part of the consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. In addition, all of Burke's stock options, totaling 25,964; 18,574; 36,111; 45,423; 30,474; 42,467; and 74,872 shares, were cancelled and converted into the right to receive a cash payment. This cash payment was calculated based on the difference between $14.50 per share and the exercise price of each option. All reported stock options were fully vested at the time of the merger. Following these transactions, Burke holds no shares of Common Stock or stock options directly.